- Scope of the procurement
- Lot 1. CM/PHR/22/5660/01 - NHS Framework Agreement for the supply of Adalimumab
- Lot 2. CM/PHR/22/5660/02 - NHS Framework Agreement for the supply of Adalimumab
- Lot 3. CM/PHR/22/5660/03 - NHS Framework Agreement for the supply of Adalimumab
- Lot 4. CM/PHR/22/5660/04 - NHS Framework Agreement for the supply of Adalimumab
Section one: Contracting authority
one.1) Name and addresses
NHS England
Quarry House, Quarry Hill
Leeds
LS2 7UE
Contact
Katie Noonan
Country
United Kingdom
NUTS code
UK - United Kingdom
Internet address(es)
Main address
Buyer's address
one.2) Information about joint procurement
The contract is awarded by a central purchasing body
one.4) Type of the contracting authority
Ministry or any other national or federal authority
one.5) Main activity
Health
Section two: Object
two.1) Scope of the procurement
two.1.1) Title
National Framework Agreement for Adalimumab Injection 1 April 2023
Reference number
CM/PHR/22/5660
two.1.2) Main CPV code
- 33600000 - Pharmaceutical products
two.1.3) Type of contract
Supplies
two.1.4) Short description
Project Title: NHS National Framework Agreement for the supply of Adalimumab Injection commencing 1 April 2023
Offer reference number: CM/PHR/22/5660
CM/PHR/22/5660/01 - NHS Framework Agreement for the supply of Adalimumab Injection to South of England. Period of framework: 1 April 2023 to 31 August 2024 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months
CM/PHR/22/5660/02 - NHS Framework Agreement for the supply of Adalimumab Injection to the Midlands and East. Period of framework: 1 April 2023 to 28 February 2025 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months
CM/PHR/22/5660/03 - NHS Framework Agreement for the supply of Adalimumab Injection to London. Period of framework: 1 April 2023 to 31 August 2025 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months
CM/PHR/22/5660/04 - NHS Framework Agreement for the supply of Adalimumab Injection to North of England. Period of framework: 1 April 2023 to 28 February 2026 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months
two.1.6) Information about lots
This contract is divided into lots: Yes
two.1.7) Total value of the procurement (excluding VAT)
Value excluding VAT: £507,314,000
two.2) Description
two.2.1) Title
CM/PHR/22/5660/01 - NHS Framework Agreement for the supply of Adalimumab
Lot No
1
two.2.2) Additional CPV code(s)
- 33600000 - Pharmaceutical products
two.2.3) Place of performance
NUTS codes
- UK - United Kingdom
Main site or place of performance
Please refer to Document No. 03, Schedule 8 in the ITO Documents for the list of Purchasing Points
two.2.4) Description of the procurement
Lot 1 - CM/PHR/22/5660/01 - NHS Framework Agreement for the supply of Adalimumab Injection to South of England. Period of framework: 1 April 2023 to 31 August 2024 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months
two.2.5) Award criteria
Price
two.2.11) Information about options
Options: Yes
Description of options
Option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months
two.2.13) Information about European Union Funds
The procurement is related to a project and/or programme financed by European Union funds: No
two.2.14) Additional information
Price is not the only award criterion and all criteria are stated only in the procurement documents
two.2) Description
two.2.1) Title
CM/PHR/22/5660/02 - NHS Framework Agreement for the supply of Adalimumab
Lot No
2
two.2.2) Additional CPV code(s)
- 33600000 - Pharmaceutical products
two.2.3) Place of performance
NUTS codes
- UK - United Kingdom
Main site or place of performance
Please refer to Document No. 03, Schedule 8 in the ITO Documents for the list of Purchasing Points
two.2.4) Description of the procurement
Lot 2 - CM/PHR/22/5660/02 - NHS Framework Agreement for the supply of Adalimumab Injection to the Midlands and East. Period of framework: 1 April 2023 to 28 February 2025 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months
two.2.5) Award criteria
Price
two.2.11) Information about options
Options: Yes
Description of options
Option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months
two.2.13) Information about European Union Funds
The procurement is related to a project and/or programme financed by European Union funds: No
two.2.14) Additional information
Price is not the only award criterion and all criteria are stated only in the procurement documents
two.2) Description
two.2.1) Title
CM/PHR/22/5660/03 - NHS Framework Agreement for the supply of Adalimumab
Lot No
3
two.2.2) Additional CPV code(s)
- 33600000 - Pharmaceutical products
two.2.3) Place of performance
NUTS codes
- UK - United Kingdom
Main site or place of performance
Please refer to Document No. 03, Schedule 8 in the ITO Documents for the list of Purchasing Points
two.2.4) Description of the procurement
Lot 3 - CM/PHR/22/5660/03 - NHS Framework Agreement for the supply of Adalimumab Injection to the London. Period of framework: 1 April 2023 to 31 August 2025 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months
two.2.5) Award criteria
Price
two.2.11) Information about options
Options: Yes
Description of options
Option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months
two.2.13) Information about European Union Funds
The procurement is related to a project and/or programme financed by European Union funds: No
two.2.14) Additional information
Price is not the only award criterion and all criteria are stated only in the procurement documents
two.2) Description
two.2.1) Title
CM/PHR/22/5660/04 - NHS Framework Agreement for the supply of Adalimumab
Lot No
4
two.2.2) Additional CPV code(s)
- 33600000 - Pharmaceutical products
two.2.3) Place of performance
NUTS codes
- UK - United Kingdom
Main site or place of performance
Please refer to Document No. 03, Schedule 8 in the ITO Documents for the list of Purchasing Points
two.2.4) Description of the procurement
Lot 4 - CM/PHR/22/5660/04 - NHS Framework Agreement for the supply of Adalimumab Injection to the North of England. Period of framework: 1 April 2023 to 28 February 2026 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months
two.2.5) Award criteria
Price
two.2.11) Information about options
Options: Yes
Description of options
Option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months
two.2.13) Information about European Union Funds
The procurement is related to a project and/or programme financed by European Union funds: No
two.2.14) Additional information
Price is not the only award criterion and all criteria are stated only in the procurement documents
Section four. Procedure
four.1) Description
four.1.1) Type of procedure
Open procedure
four.1.3) Information about a framework agreement or a dynamic purchasing system
The procurement involves the establishment of a framework agreement
four.1.8) Information about the Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement: Yes
four.2) Administrative information
four.2.1) Previous publication concerning this procedure
Notice number: 2022/S 000-030223
Section five. Award of contract
Lot No
2
Title
Lot 2 - CM/PHR/22/5660/02 - NHS Framework Agreement for the supply of Adalimumab
A contract/lot is awarded: Yes
five.2) Award of contract
five.2.1) Date of conclusion of the contract
14 March 2023
five.2.2) Information about tenders
Number of tenders received: 7
Number of tenders received from SMEs: 1
Number of tenders received from tenderers from other EU Member States: 7
Number of tenders received from tenderers from non-EU Member States: 0
Number of tenders received by electronic means: 7
The contract has been awarded to a group of economic operators: No
five.2.3) Name and address of the contractor
Amgen Ltd
216 Science Park Milton Road
Cambridge
CB4 0WA
Country
United Kingdom
NUTS code
- UK - United Kingdom
National registration number
2354269
The contractor is an SME
No
five.2.4) Information on value of contract/lot (excluding VAT)
Initial estimated total value of the contract/lot: £137,087,000
Total value of the contract/lot: £1
Section five. Award of contract
Lot No
2
Title
Lot 2 - CM/PHR/22/5660/02 - NHS Framework Agreement for the supply of Adalimumab
A contract/lot is awarded: Yes
five.2) Award of contract
five.2.1) Date of conclusion of the contract
14 March 2023
five.2.2) Information about tenders
Number of tenders received: 7
Number of tenders received from SMEs: 1
Number of tenders received from tenderers from other EU Member States: 7
Number of tenders received from tenderers from non-EU Member States: 0
Number of tenders received by electronic means: 7
The contract has been awarded to a group of economic operators: No
five.2.3) Name and address of the contractor
Sandoz Ltd
Park View, Riverside Way, Watchmoor Park,
Camberley, Surrey.
GU15 3YL
Country
United Kingdom
NUTS code
- UK - United Kingdom
National registration number
01547204
The contractor is an SME
Yes
five.2.4) Information on value of contract/lot (excluding VAT)
Initial estimated total value of the contract/lot: £137,087,000
Total value of the contract/lot: £1
Section five. Award of contract
Lot No
2
Title
Lot 2 - CM/PHR/22/5660/02 - NHS Framework Agreement for the supply of Adalimumab
A contract/lot is awarded: Yes
five.2) Award of contract
five.2.1) Date of conclusion of the contract
14 March 2023
five.2.2) Information about tenders
Number of tenders received: 7
Number of tenders received from SMEs: 1
Number of tenders received from tenderers from other EU Member States: 7
Number of tenders received from tenderers from non-EU Member States: 0
Number of tenders received by electronic means: 7
The contract has been awarded to a group of economic operators: No
five.2.3) Name and address of the contractor
Biogen
Innovation House 70 Norden Road
Maidenhead Berkshire
SL6 4AY
Country
United Kingdom
NUTS code
- UK - United Kingdom
National registration number
01497267
The contractor is an SME
No
five.2.4) Information on value of contract/lot (excluding VAT)
Initial estimated total value of the contract/lot: £137,087,000
Total value of the contract/lot: £1
Section five. Award of contract
Lot No
2
Title
Lot 2 - CM/PHR/22/5660/02 - NHS Framework Agreement for the supply of Adalimumab
A contract/lot is awarded: Yes
five.2) Award of contract
five.2.1) Date of conclusion of the contract
14 March 2023
five.2.2) Information about tenders
Number of tenders received: 7
Number of tenders received from SMEs: 1
Number of tenders received from tenderers from other EU Member States: 7
Number of tenders received from tenderers from non-EU Member States: 0
Number of tenders received by electronic means: 7
The contract has been awarded to a group of economic operators: No
five.2.3) Name and address of the contractor
Abbvie Ltd
Abbvie House, Vanwall Business Park, Vanwall Road,
Maidenhead, Berks.
SL6 4UB
Country
United Kingdom
NUTS code
- UK - United Kingdom
National registration number
08004972
The contractor is an SME
No
five.2.4) Information on value of contract/lot (excluding VAT)
Initial estimated total value of the contract/lot: £137,087,000
Total value of the contract/lot: £1
Section five. Award of contract
Lot No
2
Title
Lot 2 - CM/PHR/22/5660/02 - NHS Framework Agreement for the supply of Adalimumab
A contract/lot is awarded: Yes
five.2) Award of contract
five.2.1) Date of conclusion of the contract
14 March 2023
five.2.2) Information about tenders
Number of tenders received: 7
Number of tenders received from SMEs: 1
Number of tenders received from tenderers from other EU Member States: 7
Number of tenders received from tenderers from non-EU Member States: 0
Number of tenders received by electronic means: 7
The contract has been awarded to a group of economic operators: No
five.2.3) Name and address of the contractor
Fresenius Kabi Limited
Cestrian Court, Eastgate Way, Manor Park,
Runcorn, Cheshire,
WA7 1NT
Country
United Kingdom
NUTS code
- UK - United Kingdom
National registration number
2182135
The contractor is an SME
No
five.2.4) Information on value of contract/lot (excluding VAT)
Initial estimated total value of the contract/lot: £137,087,000
Total value of the contract/lot: £1
Section five. Award of contract
Lot No
2
Title
Lot 2 - CM/PHR/22/5660/02 - NHS Framework Agreement for the supply of Adalimumab
A contract/lot is awarded: Yes
five.2) Award of contract
five.2.1) Date of conclusion of the contract
14 March 2023
five.2.2) Information about tenders
Number of tenders received: 7
Number of tenders received from SMEs: 1
Number of tenders received from tenderers from other EU Member States: 7
Number of tenders received from tenderers from non-EU Member States: 0
Number of tenders received by electronic means: 7
The contract has been awarded to a group of economic operators: No
five.2.3) Name and address of the contractor
Celltrion Healthcare United Kingdom Limited
The Switch ,1-7 The Grove,
Slough
SL1 1QP
Country
United Kingdom
NUTS code
- UK - United Kingdom
National registration number
11685363
The contractor is an SME
No
five.2.4) Information on value of contract/lot (excluding VAT)
Initial estimated total value of the contract/lot: £137,087,000
Total value of the contract/lot: £1
Section six. Complementary information
six.4) Procedures for review
six.4.1) Review body
The High Court
The Strand
London
WC2A 2LL
Country
United Kingdom